New Assay Sheds Light on New Strategies for Arthritis Drug - 360Dx

New Assay Sheds Light on New Strategies for Arthritis Drug  360Dx

The "drug-tolerant assay" found that only very early TNF levels offered treatment response clues in RA patients treated with the TNF inhibitor adalimumab.



Comments

Popular posts from this blog

Fibromyalgia — Latest Stories — Pain News Network

Chronic Lyme arthritis: A mystery solved?

Epstein-Barr virus and autoimmune diseases